1. Home
  2. NKTX vs DAVA Comparison

NKTX vs DAVA Comparison

Compare NKTX & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.07

Market Cap

198.2M

Sector

Health Care

ML Signal

HOLD

Logo Endava plc (each representing one)

DAVA

Endava plc (each representing one)

HOLD

Current Price

$2.97

Market Cap

159.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTX
DAVA
Founded
2015
2000
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
159.1M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
NKTX
DAVA
Price
$2.07
$2.97
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$11.33
$13.50
AVG Volume (30 Days)
795.2K
262.4K
Earning Date
05-11-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
11.88
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.07
P/E Ratio
N/A
$20.02
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$2.55
52 Week High
$3.72
$14.99

Technical Indicators

Market Signals
Indicator
NKTX
DAVA
Relative Strength Index (RSI) 29.92 50.14
Support Level $1.93 $2.64
Resistance Level $2.22 $3.03
Average True Range (ATR) 0.15 0.14
MACD -0.06 0.03
Stochastic Oscillator 3.68 42.31

Price Performance

Historical Comparison
NKTX
DAVA

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About DAVA Endava plc (each representing one)

Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.

Share on Social Networks: